Is AI helping or harming Gen Z Americans with mental health conditions?
New Bryter research shows Gen Z patients with diagnosed generalized anxiety and/or major depressive disorders are rapidly adopting AI chatbots – often downplaying accuracy, empathy, and risk. Additional insights demonstrate the potential role for pharma.
- Survey of 1000 adults in the US diagnosed with Generalized Anxiety Disorder (GAD) or Major Depressive Disorder (MDD)
- Patient views of AI vs traditional therapeutic care
- Key differences in attitude to and usage of AI for mental health support by age group
- Patients' views of where the pharmaceutical industry can play a role
- Key recommendations for those working in the pharmaceutical industry
Fill in the form to receive a copy of the full report direct to your inbox
To learn more about innovations in digital health and how these technologies are shaping patient expectations and experience, check out our article 'Innovation in digital health'
- Survey of 1000 adults in the US diagnosed with Generalized Anxiety Disorder (GAD) or Major Depressive Disorder (MDD)
- Patient views of AI vs traditional therapeutic care
- Key differences in attitude to and usage of AI for mental health support by age group
- Patients' views of where the pharmaceutical industry can play a role
- Key recommendations for those working in the pharmaceutical industry
Fill in the form to receive a copy of the full report direct to your inbox
To learn more about innovations in digital health and how these technologies are shaping patient expectations and experience, check out our article 'Innovation in digital health'